HOME >> BIOLOGY >> NEWS
Risk of ectopic pregnancies after IVF declines with age in women with tubal disease

Madrid, Spain: The first study to look at the risk of ectopic [1] pregnancies after IVF in a complete national ART register has unearthed a surprising result, a conference of international fertility experts heard today (Tuesday 1 July).

The researchers found that women face a slightly increased risk of ectopic pregnancies after IVF. More surprisingly, they found that whereas in the normal population the risk of an ectopic pregnancy increases with women's age, after IVF the risk decreases with age in women who have had diseased Fallopian tubes.

Elizabeth Asung, an honorary research fellow at Leeds University and The Bridge Centre in London, UK, told the annual conference of the European Society of Human Reproduction and Embryology that she had analysed data from the UK's Human Fertilization and Embryology Authority (HFEA) on 97,240 women, aged between 18-50 who underwent either straightforward IVF embryo transfer (IVF-ET) or embryo transfer after ICSI (ICSI-ET) between 1991 and 1999.

She and her colleagues found that after ICSI-ET the incidence of ectopic pregnancies was 1.3% a figure that places it firmly in the range of incidence in the normal population. However, after IVF-ET the numbers increased by roughly a half from between 1-2% in the normal population to 2.8%.

Ms Asung said: "The difference in the numbers of ectopic pregnancies after IVF-ET and ICSI-ET may be because with ICSI the women tend to have no or fewer abnormalities associated with infertility because it's the man's fertility that is at issue. Whereas with IVF there's a higher proportion of women with compounding problems such as tubal disease, which may be contributing to their infertility and which are risk factors for ectopic pregnancies."

The study found that when women's Fallopian tubes had been damaged by tubal disease, the numbers of ectopic pregnancies increased to 6.1% in women under the age of 25, 4.1% between 25 and 29, 3.9% between 30 a
'"/>

Contact: Emma Mason
wordmason@aol.com
44-0-1376-563090
European Society for Human Reproduction and Embryology
1-Jul-2003


Page: 1 2 3

Related biology news :

1. Marijuana use could cause tubal pregnancies
2. Study finds two-thirds of unplanned pregnancies in women using contraception
3. Component in plastic bottles found to cause abnormal pregnancies in mice
4. Researchers concerned over early egg retrieval after cancer treatment - doctors advised to monitor pregnancies as mice study reveals problems
5. Ringling Bros. announces four Asian elephant pregnancies at Center for Elephant Conservation
6. Common enzyme deficiency may jeopardize pregnancies
7. Preclinical safety study shows adipose-derived stem cells improve heart function after heart attack
8. Why your knees and quads hurt more after running than walking: Youre only human
9. Fluid derived from aloe plant prolongs life after hemorrhagic shock in animal study
10. Researchers find that color perception is not innate, but acquired after birth
11. Reading hexametric rhyme supports cardiac synchronization, especially after a heart attack

Post Your Comments:
(Date:10/16/2014)... conventional thinking on how the bowel lining develops and, ... bowel cancer starts. , The researchers produced evidence that ... ,crypts, that are a feature of the bowel lining, ... cancer development, a controversial finding as scientists are still ... imaging technologies, Dr Chin Wee Tan and Professor Tony ...
(Date:10/16/2014)... Syncytial Virus causes severe respiratory tract infections and ... year. Scientists at VIB and Ghent University have ... counteract this common virus infection. , Xavier ... that paves the way for the development of ... virus that causes suffering in numerous small children ...
(Date:10/16/2014)... NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market announces ... the Smart Wallet, at the 13 th annual ... global conference on the intersection of technology and the ... , founder and publisher of the Strategic News Service™, ...
Breaking Biology News(10 mins):Cryptic clues drive new theory of bowel cancer development 2New perspectives for development of an RSV vaccine 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 3
(Date:10/22/2014)... BOSTON , Oct. 22, 2014 /PRNewswire/ ... global specialty pharmaceutical company, and Rhythm, a biopharmaceutical company, ... option to acquire Rhythm,s wholly owned subsidiary, Rhythm Health, ... agonist, for the treatment of diabetic gastroparesis and other ... a successful Phase 2 trial of relamorelin for the ...
(Date:10/22/2014)... WriteResult, LLC – a premier provider ... with a team of researchers from Yale University’s School ... Collaborative to provide electronic questionnaire data collection through use ... started in May, aims to evaluate the impact of ... to and participation in urban agriculture to impact their ...
(Date:10/22/2014)... , Oct. 22, 2014   Synthetic Biologics, Inc. ... pathogen-specific therapies for serious infections and diseases, announced today ... a Notice of Allowance for a composition of matter ... C. difficile program, SYN-004. This is Synthetic Biologics, ... the U.S. and adds to the Company,s extensive ...
(Date:10/20/2014)... The report “Pharmacy Automation Systems Market ... Labeling Systems, Table-top Counters) by End-user (Inpatient Pharmacy ... Trends to 2019” analyzes and studies the major ... Europe, Asia-Pacific, and the Rest of the World ... figures spread through 300 pages and in-depth TOC ...
Breaking Biology Technology:Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 2Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 5myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 2myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4
Cached News: